Enviva Complex Care Limited 03869350 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is domiciliary care services. Digita Accounts Production Advanced 6.30.9574.0 true true true false false false false false 03869350 2024-04-01 2025-03-31 03869350 2025-03-31 03869350 bus:Director2 2025-03-31 03869350 bus:Director3 2025-03-31 03869350 bus:OrdinaryShareClass1 2025-03-31 03869350 bus:Consolidated 2025-03-31 03869350 core:AcceleratedTaxDepreciationDeferredTax 2025-03-31 03869350 core:RetainedEarningsAccumulatedLosses 2025-03-31 03869350 core:ShareCapital 2025-03-31 03869350 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 03869350 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-03-31 03869350 core:Goodwill 2025-03-31 03869350 core:BetweenTwoFiveYears 2025-03-31 03869350 core:WithinOneYear 2025-03-31 03869350 core:FurnitureFittingsToolsEquipment 2025-03-31 03869350 bus:FRS102 2024-04-01 2025-03-31 03869350 bus:Audited 2024-04-01 2025-03-31 03869350 bus:FullAccounts 2024-04-01 2025-03-31 03869350 bus:RegisteredOffice 2024-04-01 2025-03-31 03869350 bus:Director1 2024-04-01 2025-03-31 03869350 bus:Director2 2024-04-01 2025-03-31 03869350 bus:Director3 2024-04-01 2025-03-31 03869350 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 03869350 bus:Consolidated 2024-04-01 2025-03-31 03869350 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 03869350 core:FinancialGuarantees 2024-04-01 2025-03-31 03869350 core:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 03869350 core:ShareCapital 2024-04-01 2025-03-31 03869350 core:ComputerSoftware 2024-04-01 2025-03-31 03869350 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-04-01 2025-03-31 03869350 core:Goodwill 2024-04-01 2025-03-31 03869350 core:LandBuildingsUnderOperatingLeases 2024-04-01 2025-03-31 03869350 core:PlantEquipmentOtherAssetsUnderOperatingLeases 2024-04-01 2025-03-31 03869350 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 03869350 core:LeaseholdImprovements 2024-04-01 2025-03-31 03869350 core:Subsidiary1 2024-04-01 2025-03-31 03869350 core:Subsidiary1 1 2024-04-01 2025-03-31 03869350 core:Subsidiary2 2024-04-01 2025-03-31 03869350 core:Subsidiary2 1 2024-04-01 2025-03-31 03869350 core:Subsidiary3 2024-04-01 2025-03-31 03869350 core:Subsidiary3 1 2024-04-01 2025-03-31 03869350 core:UKTax 2024-04-01 2025-03-31 03869350 1 2024-04-01 2025-03-31 03869350 countries:EnglandWales 2024-04-01 2025-03-31 03869350 2024-03-31 03869350 core:RetainedEarningsAccumulatedLosses 2024-03-31 03869350 core:ShareCapital 2024-03-31 03869350 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-03-31 03869350 core:Goodwill 2024-03-31 03869350 core:FurnitureFittingsToolsEquipment 2024-03-31 03869350 2023-04-01 2024-03-31 03869350 2024-03-31 03869350 bus:OrdinaryShareClass1 2024-03-31 03869350 core:AcceleratedTaxDepreciationDeferredTax 2024-03-31 03869350 core:RetainedEarningsAccumulatedLosses 2024-03-31 03869350 core:ShareCapital 2024-03-31 03869350 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 03869350 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-03-31 03869350 core:Goodwill 2024-03-31 03869350 core:CostValuation 2024-03-31 03869350 core:ProvisionsForImpairmentInvestments 2024-03-31 03869350 core:BetweenTwoFiveYears 2024-03-31 03869350 core:WithinOneYear 2024-03-31 03869350 core:FurnitureFittingsToolsEquipment 2024-03-31 03869350 core:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 03869350 core:ShareCapital 2023-04-01 2024-03-31 03869350 core:LandBuildingsUnderOperatingLeases 2023-04-01 2024-03-31 03869350 core:PlantEquipmentOtherAssetsUnderOperatingLeases 2023-04-01 2024-03-31 03869350 core:Subsidiary1 1 2023-04-01 2024-03-31 03869350 core:Subsidiary2 1 2023-04-01 2024-03-31 03869350 core:Subsidiary3 1 2023-04-01 2024-03-31 03869350 core:UKTax 2023-04-01 2024-03-31 03869350 2023-03-31 03869350 core:RetainedEarningsAccumulatedLosses 2023-03-31 03869350 core:ShareCapital 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 03869350

Enviva Complex Care Limited
Annual Report and Financial Statements
for the Year Ended 31 March 2025

Enviva Complex Care Limited

Contents

Company Information | 1
Strategic Report | 2
Directors' Report | 3
Statement of Directors' Responsibilities | 4
Independent Auditor's Report | 5 to 7
Profit and Loss Account | 8
Balance Sheet | 9
Statement of Changes in Equity | 10
Notes to the Financial Statements | 11 to 19

Enviva Complex Care Limited

Company Information

Directors | J M Lee A M Miller

Registered office | Suite A, Ground Floor Trinity Court Molly Millars Lane Wokingham RG41 2PY

Auditors | Hazlewoods LLP Windsor House Bayshill Road Cheltenham GL50 3AT

Enviva Complex Care Limited

Strategic Report for the Year Ended 31 March 2025

The directors present their strategic report for the year ended 31 March 2025.

Principal activity

The principal activity of the company is domiciliary care services.

Fair review of the business

The results for the year, which are set out in the profit and loss account, show turnover of £17,922,217 (2024 - £21,810,862) and an operating loss of £2,936,121 (2024 - £921,322). At 31 March 2025, the company had net assets of £3,760,635 (2024 - £6,701,184). The trade and assets of the company have been sold post year end and management intend to liquidate the company in the near future. The financial statements have therefore not been prepared on a going concern basis. This has not resulted in any material adjustments to the amounts in the financial statements.

Given the nature of the business, the directors are of the opinion that key performance indicators are important. The company uses a number of indicators to monitor and improve the position of the business. Indicators are reviewed and altered to meet changes both in the internal and external environments. The directors do not consider the inclusion of an analysis using key performance indicators to be necessary to assist users of the financial statements in their understanding of the financial performance or position of the company.

Principal risks and uncertainties

The management of the business and the execution of the company's strategy are subject to a number of risks. The key business risks and uncertainties affecting the company are considered to relate to ongoing compliance with current and future legislation affecting the sector.

Approved by the Board on 16 July 2026 and signed on its behalf by:

A M Miller
Director

Enviva Complex Care Limited

Directors' Report for the Year Ended 31 March 2025

The directors present their report and the financial statements for the year ended 31 March 2025.

Directors of the company

The directors who held office during the year were as follows:

J M Lee

A M Miller (appointed 20 June 2024)

D J Cole (resigned 20 May 2026)

Financial instruments

Objectives and policies

The board constantly monitors the company's trading results and revise projections as appropriate to ensure that the company can meet its future obligations as they fall due.

Price risk, credit risk, liquidity risk and cash flow risk

The company is exposed to the usual credit and cash flow risks associated with selling on credit and manages this through credit control procedures.

Employment of disabled persons

The company’s policy is to consider the recruitment of disabled workers for those vacancies that they are able to fill. All necessary assistance with initial training courses is given. Once employed, a career plan is developed so as to ensure suitable opportunities for each disabled person. Arrangements are made, wherever possible, for retraining employees who become disabled, to enable them to perform work identified as appropriate to their aptitudes and abilities.

Employee involvement

The company encourages the involvement of employees in its management through regular departmental meetings.

Important non adjusting events after the financial period

Post year end on 10 July 2025 the trade and assets of the company were sold to a fellow subsidiary undertaking.

Disclosure of information to the auditors

Each director has taken steps that they ought to have taken as a director in order to make themselves aware of any relevant audit information and to establish that the company's auditors are aware of that information. The directors confirm that there is no relevant information that they know of and of which they know the auditors are unaware.

Reappointment of auditors

Hazlewoods LLP have expressed their willingness to continue in office.

Approved by the Board on 16 July 2026 and signed on its behalf by:

A M Miller
Director

Enviva Complex Care Limited

Statement of Directors' Responsibilities

The directors acknowledge their responsibilities for preparing the Strategic Report, Directors' Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

• | select suitable accounting policies and apply them consistently;

• | make judgements and accounting estimates that are reasonable and prudent;

• | state whether applicable United Kingdom Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

• | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Enviva Complex Care Limited

Independent Auditor's Report to the Members of Enviva Complex Care Limited

Opinion

We have audited the financial statements of Enviva Complex Care Limited (the 'company') for the year ended 31 March 2025, which comprise the Profit and Loss Account, Balance Sheet, Statement of Changes in Equity, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

• | give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its loss for the year then ended;
• | have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
• | have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Emphasis of matter
We draw your attention to note 2 to the financial statements which explains that post year end the the trade and assets of the company have been sold and management intend to liquidate the company and therefore do not consider it to be appropriate to adopt the going concern basis of accounting in preparing the financial statements. Accordingly the financial statements have been prepared on a basis other than going concern as described in Note 2. Our opinion is not modified in respect of this matter.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Enviva Complex Care Limited

Independent Auditor's Report to the Members of Enviva Complex Care Limited

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

• | the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

• | the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

• | adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
• | the financial statements are not in agreement with the accounting records and returns; or
• | certain disclosures of directors' remuneration specified by law are not made; or
• | we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities set out on page 4, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Extent to which the audit was capable of detecting irregularities, including fraud
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
We considered the nature of the company’s industry and its control environment and reviewed the company’s documentation of their policies and procedures relating to fraud and compliance with laws and regulations. We also enquired of management about their own identification and assessment of the risks of irregularities.
We obtained an understanding of the legal and regulatory framework that the company operates in and identified the key laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements, including the UK Companies Act and tax legislation, and, those that do not have a direct effect on the financial statements but compliance with which may be fundamental to the company’s ability to operate or to avoid a material penalty.
We discussed among the audit engagement team regarding the opportunities and incentives that may exist within the organisation for fraud and how and where fraud might occur in the financial statements.

Enviva Complex Care Limited

Independent Auditor's Report to the Members of Enviva Complex Care Limited

In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override. In addressing the risk of fraud through management override of controls, we tested the appropriateness of journal entries and other adjustments; assessed whether the judgments made in accounting estimates are indicative of a potential bias; and evaluated the business rationale of any significant transactions that are unusual or outside the normal course of business.
In addition to the above, our procedures to respond to the risks identified included the following:

• | reviewing financial statement disclosures by testing to supporting documentation to assess compliance with provisions of relevant laws and regulations described as having a direct effect on the financial statements;

• | performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatements due to fraud;

• | enquiring of management concerning actual and potential litigation and claims and instances of non-compliance with laws and regulations; and

• | reading minutes of meetings of those charged with governance.

Our audit procedures were designed to respond to risks of material misstatement in the financial statements, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery, misrepresentations or through collusion. There are inherent limitations in the audit procedures performed and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we are to become aware of it.

A further description of our responsibilities is available on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report
This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Joanne Hartness (Senior Statutory Auditor)
For and on behalf of Hazlewoods LLP, Statutory Auditor
Windsor House
Bayshill Road
Cheltenham
GL50 3AT

16 July 2026

Enviva Complex Care Limited

Profit and Loss Account for the Year Ended 31 March 2025

| Note | 2025 £ | 2024 £
Turnover | 3 | 17,922,217 | 21,810,862
Cost of sales |  | (13,253,175) | (15,295,094)
Gross profit |  | 4,669,042 | 6,515,768
Administrative expenses |  | (5,378,585) | (5,836,141)
Exceptional items | 5 | (2,226,578) | (1,600,949)
Operating loss |  | (2,936,121) | (921,322)
Other interest receivable and similar income | 6 | 20 | 20
Interest payable and similar charges | 7 | (4,448) | -
Loss before tax | 4 | (2,940,549) | (921,302)
Taxation | 11 | - | -
Loss for the financial year |  | (2,940,549) | (921,302)

The above results were derived from continuing operations.

The company has no recognised gains or losses for the year other than the results above.

Enviva Complex Care Limited

(Registration number: 03869350)
Balance Sheet as at 31 March 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Intangible assets | 12 | 3,537,801 | 3,904,065
Tangible assets | 13 | 147,337 | 236,066
Investments | 14 | - | -
|  | 3,685,138 | 4,140,131
Current assets |  |  |
Debtors | 15 | 2,282,830 | 4,471,312
Cash at bank and in hand |  | 332,032 | 91,877
|  | 2,614,862 | 4,563,189
Creditors: Amounts falling due within one year | 16 | (2,538,561) | (2,001,332)
Net current assets |  | 76,301 | 2,561,857
Total assets less current liabilities |  | 3,761,439 | 6,701,988
Provisions for liabilities | 11 | (804) | (804)
Net assets |  | 3,760,635 | 6,701,184
Capital and reserves |  |  |
Called up share capital | 18 | 1,000 | 1,000
Profit and loss account |  | 3,759,635 | 6,700,184
Total equity |  | 3,760,635 | 6,701,184

Approved and authorised by the Board on 16 July 2026 and signed on its behalf by:

A M Miller
Director

Enviva Complex Care Limited

Statement of Changes in Equity for the Year Ended 31 March 2025

| Share capital £ | Profit and loss account £ | Total £
At 1 April 2024 | 1,000 | 6,700,184 | 6,701,184
Loss for the year | - | (2,940,549) | (2,940,549)
At 31 March 2025 | 1,000 | 3,759,635 | 3,760,635

| Share capital £ | Profit and loss account £ | Total £
At 1 April 2023 | 1,000 | 7,621,486 | 7,622,486
Loss for the year | - | (921,302) | (921,302)
At 31 March 2024 | 1,000 | 6,700,184 | 6,701,184

Enviva Complex Care Limited

Notes to the Financial Statements for the Year Ended 31 March 2025

| 1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Suite A, Ground Floor
Trinity Court
Molly Millars Lane
Wokingham
RG41 2PY

| 2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland and the Companies Act 2006'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Summary of disclosure exemptions

The company has not presented a cash flow statement on the grounds that the company is a wholly owned subsidiary and a group cash flow statement is included in the financial statements of the ultimate parent company.

Name of parent of group

These financial statements are consolidated in the financial statements of Sonderwell Topco Limited.

The financial statements of Sonderwell Topco Limited may be obtained from Companies House.

Going concern

The trade and assets of the company have been sold post year end and management intend to liquidate the company in the near future. The financial statements have therefore not been prepared on a going concern basis. This has not resulted in any material adjustments to the amounts in the financial statements.

Judgements and estimation uncertainty

These financial statements do not contain any significant judgements or estimation uncertainty.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company. The company recognises revenue when the amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities.

Government grants

Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in income over the period in which the related costs are recognised. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.

Enviva Complex Care Limited

Notes to the Financial Statements for the Year Ended 31 March 2025

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Fixtures, fittings, furniture and equipment | 25% - 33.3% straight line
Leasehold improvements | Straight line over 5 years

Intangible assets

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.
Negative goodwill arising on an acquisition is recognised on the face of the balance sheet on the acquisition date and subsequently the excess up to the fair value of non-monetary assets acquired is recognised in profit or loss in the periods in which the non-monetary assets are recovered.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class | Amortisation method and rate
Goodwill | Straight line over 10 years
Computer software | 33.3% straight Line

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.
Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Enviva Complex Care Limited

Notes to the Financial Statements for the Year Ended 31 March 2025

Trade debtors

Trade debtors are amounts due from customers for services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments
Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.
Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Enviva Complex Care Limited

Notes to the Financial Statements for the Year Ended 31 March 2025

Financial instruments (continued)
Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.
A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.
The recoverable amount of goodwill is derived from measurement of the present value of the future cash flows of the cash-generating units ('CGUs') of which the goodwill is a part. Any impairment loss in respect of a CGU is allocated first to the goodwill attached to that CGU, and then to other assets within that CGU on a pro-rata basis.
Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. Where a reversal of impairment occurs in respect of a CGU, the reversal is applied first to the assets (other than goodwill) of the CGU on a pro-rata basis and then to any goodwill allocated to that CGU.
For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.
For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.
Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

| 3 | Turnover

The total turnover of the company has been derived from its principal activity wholly undertaken in the United Kingdom.

| 4 | Profit before tax

Arrived at after charging:

| 2025 £ | 2024 £
Depreciation expense | 91,409 | 55,262
Amortisation expense | 455,704 | 433,785
Operating lease expense - property | 107,431 | 180,441
Operating lease expense - plant and machinery | 1,893 | 2,530

| 5 | Exceptional items

| 2025 £ | 2024 £
Exceptional expenses | 2,226,578 | 1,600,949

Exceptional items in the current year consists of provisions against intercompany debt, employee disputes, consultancy costs, property closures, role redundancies and new office costs.
Exceptional items in the prior year consisted of provisions against an intercompany debt, one-off salary costs, recruitments, agency, legal and professional fees, and costs associated with office closure.

Enviva Complex Care Limited

Notes to the Financial Statements for the Year Ended 31 March 2025

| 6 | Other interest receivable and similar income

| 2025 £ | 2024 £
Interest income on bank deposits | 20 | 20

| 7 | Interest payable and similar expenses

| 2025 £ | 2024 £
Interest expense on other finance liabilities | 4,448 | -

| 8 | Staff costs

The aggregate payroll costs (including directors' remuneration) were as follows:

| 2025 £ | 2024 £
Wages and salaries | 13,931,163 | 15,672,369
Social security costs | 1,355,085 | 1,485,901
Pension costs, defined contribution scheme | 269,811 | 295,246
| 15,556,059 | 17,453,516

The average number of persons employed by the company (including directors) during the year, analysed by category was as follows:

| 2025 No. | 2024 No.
Care and administration | 495 | 598

| 9 | Directors' remuneration

Directors' remuneration has been borne by a connected party.

| 10 | Auditors' remuneration

Auditors' remuneration has been borne by a connected party.

Enviva Complex Care Limited

Notes to the Financial Statements for the Year Ended 31 March 2025

| 11 | Taxation

The tax on profit before tax for the year is higher than the standard rate of corporation tax in the UK (2024 - higher than the standard rate of corporation tax in the UK) of 25% (2024 - 25%).
The differences are reconciled below:

| 2025 £ | 2024 £
Loss before tax | (2,940,549) | (921,302)
Corporation tax at standard rate | (735,137) | (230,326)
Tax increase/(decrease) from effect of capital allowances and depreciation | 7,320 | (6,554)
Effect of expense not deductible in determining taxable profit (tax loss) | 497,794 | 288,321
Increase from tax losses for which no deferred tax asset was recognised | 230,023 | -
Tax decrease arising from group relief | - | (51,441)
Total tax charge/(credit) | - | -

Deferred tax

Deferred tax assets and liabilities

2025 | Liability £
Differences between accumulated depreciation and capital allowances | 804

2024 | Liability £
Differences between accumulated depreciation and capital allowances | 804

| 12 | Intangible assets

| Goodwill £ | Internally generated software development costs £ | Total £
Cost or valuation
At 1 April 2024 | 4,337,850 | - | 4,337,850
Additions | - | 68,440 | 68,440
Transfer between asset class | - | 21,600 | 21,600
At 31 March 2025 | 4,337,850 | 90,040 | 4,427,890
Amortisation
Transfer between asset class |  |  |
At 1 April 2024 | 433,785 | - | 433,785
Amortisation charge | 433,785 | 21,919 | 455,704
Transfer between asset class | - | 600 | 600
At 31 March 2025 | 867,570 | 22,519 | 890,089
Carrying amount
At 31 March 2025 | 3,470,280 | 67,521 | 3,537,801
At 31 March 2024 | 3,904,065 | - | 3,904,065

Enviva Complex Care Limited

Notes to the Financial Statements for the Year Ended 31 March 2025

| 13 | Tangible assets

| Fixtures, fittings, furniture and equipment £
Cost
At 1 April 2024 | 416,179
Additions | 23,680
Transfer between asset class | (21,600)
At 31 March 2025 | 418,259
Depreciation
At 1 April 2024 | 180,113
Charge for the year | 91,409
Transfer between asset class | (600)
At 31 March 2025 | 270,922
Carrying amount
At 31 March 2025 | 147,337
At 31 March 2024 | 236,066

| 14 | Investments

| 2025 £ | 2024 £
Investments in subsidiaries | - | -

Subsidiaries | £
Cost
At 1 April 2024 and at 31 March 2025 | 5,188,478
Impairment |
At 1 April 2024 and at 31 March 2025 | 5,188,478
Carrying amount
At 31 March 2024 and at 31 March 2025 | -

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking | Registered office | Holding | Proportion of voting rights and shares held
|  |  | 2025 | 2024
Subsidiary undertakings
Invent Health Limited | Scotland |
Ordinary
100%
100%
Becc: Complex Care Support Limited | England and Wales |
Ordinary
100%
100%
Diversity Care Solutions Limited | England and Wales |
Ordinary
100%
100%

All subsidiary companies are dormant.

Enviva Complex Care Limited

Notes to the Financial Statements for the Year Ended 31 March 2025

| 15 | Debtors

| 2025 £ | 2024 £
Trade debtors | 1,092,534 | 2,489,068
Amounts owed by group undertakings | 612,501 | 1,460,927
Other debtors | 64,339 | 87,188
Prepayments and accrued income | 513,456 | 434,129
| 2,282,830 | 4,471,312

| 16 | Creditors

| 2025 £ | 2024 £
Due within one year |  |
Trade creditors | 150,181 | 158,369
Amounts due to group undertakings | 1,063,302 | 291,848
Social security and other taxes | 382,534 | 475,373
Outstanding defined contribution pension costs | 117,373 | 121,615
Other creditors | 235,301 | 142,846
Accrued expenses | 581,929 | 803,340
Corporation tax liability | 7,941 | 7,941
| 2,538,561 | 2,001,332

| 17 | Pension and other schemes

Defined contribution pension scheme

The company operates a defined contribution pension scheme. The pension cost charge for the year represents contributions payable by the company to the scheme and amounted to £269,811 (2024 - £295,246).
Contributions totalling £117,373 (2024 - £121,615) were payable to the scheme at the end of the year and are included in creditors.

| 18 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary shares of £1 each | 1,000 | 1,000 | 1,000 | 1,000

| 19 | Obligations under leases and hire purchase contracts

Operating leases

The total of future minimum lease payments is as follows:

| 2025 £ | 2024 £
Not later than one year | 91,290 | 94,194
Later than one year and not later than five years | 134,092 | 116,754
| 225,382 | 210,948

Enviva Complex Care Limited

Notes to the Financial Statements for the Year Ended 31 March 2025

| 20 | Contingent liabilities

The company is party to cross guarantees with other companies in the Sonderwell Topco Limited group for the bank debt due from Sonderwell Bidco Limited, which amounted to £26,750,000 (2024 - £26,750,000) at 31 March 2025. The bank loans are secured by a floating charge on the assets of the company and other group companies.

| 21 | Non adjusting events after the financial period

Post year end on 10 July 2025 the trade and assets of the company were sold to a fellow subsidiary undertaking.

| 22 | Parent and ultimate parent undertaking

At the balance sheet date the company's immediate parent was Enviva Care Limited, incorporated in England and Wales. The ultimate parent was Sonderwell Topco Limited, incorporated in England and Wales and the ultimate controlling party was August Equity Partners V GP Limited, a company registered in England and Wales, which is considered to have no single controlling party.
Following a restructure on 27 January 2026 the company's immediate parent company is Sonderwell Bidco Limited and ultimate parent company is Sonderwell Topco 2 Limited both incorporated in England and Wales. The ultimate controlling party is Five Arrows Debt Partners III Holding S.A.